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ABSTRACT 
ISCHEMIC PRECONDITIONING IMPROVES MAXIMAL ACCUMULATED 
OXYGEN DEFICIT IN NCAA DIVISION I MIDDLE-DISTANCE RUNNERS 
EMILY PAULL 
2018 
Purpose: There is an ongoing debate concerning whether ischemic preconditioning elicits 
consistent and meaningful exercise performance benefits. We have previously 
demonstrated no performance benefits of ischemic preconditioning at submaximal 
aerobic exercise intensities. It is likely that the beneficial effects of ischemic 
preconditioning on performance only involve supramaximal anaerobic exercise bouts, 
which elicit greater metabolic and neuromuscular stress. The aim of the study was to test 
the hypothesis that ischemic preconditioning improves maximal accumulated oxygen 
deficit (aO2D), an indicator of anaerobic capacity, in NCAA Division I middle-distance 
runners. Methods: A randomized sham-controlled crossover study was employed in 
which 10 NCAA Division I middle-distance (800 to 1600 meter) track athletes (age: 
21±1 yr; VO2 max: 65±7 mlO2·kg·-1·min-1) completed three supramaximal treadmill 
running trials (110% VO2max; ~12.6 mph @ 5% grade) to volitional exhaustion coupled 
with indirect calorimetry to assess maximal aO2D at baseline, after a sham control trial 
(mock preconditioning), and with limb-based ischemic preconditioning (4×5 min cycles 
of brachial artery ischemia/reperfusion). Maximal aO2D (mlO2·kg-1) for each trial was 
determined by first calculating the theoretical oxygen demand required for the 
supramaximal running bout (linear regression extrapolated from 9×5 min submaximal 
running stages). The actual oxygen demand measured during the supramaximal bout was 
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then subtracted from the theoretical value to obtain the aO2D. Statistical Analysis: A 
three-way repeated-measures ANOVA with adjustment for multiple comparisons was 
used for within-group differences (i.e., baseline vs sham vs ischemic preconditioning) in 
aO2D. Results: Ischemic preconditioning (122±38 sec) increased (P=0.0001) 
supramaximal time to exhaustion by 22% compared with both baseline (99±23 sec, 95% 
CI: 4.8-40.6, P=0.014) and sham (101±30 sec 95% CI: 6.7-34.2, P=0.001). Effect size for 
these trial differences as estimated by the Partial Eta2 (0.58) were large. Furthermore, the 
aO2D was considerably greater (P=0.009) with ischemic preconditioning. During their 
supramaximal run in the presence of ischemic preconditioning, aO2D was 46±35 
mlO2·kg-1, a substantial (Partial Eta2 = 0.43) increase compared with baseline (35±27 
mlO2·kg-1, P=0.025, 95% CI:1.3-19.2) and sham (38±32 mlO2·kg-1, P=0.046, 95% CI: 
0.13-14.0). There were no statistical differences in time to exhaustion and maximal aO2D 
between baseline and sham. Conclusions: Limb-based ischemic preconditioning 
considerably improves time to exhaustion and anaerobic capacity as measured by the 
maximal aO2D in NCAA Division I middle-distance track athletes. Additional work is 
needed to confirm whether these laboratory-based performance benefits can be translated 
to better outcomes in real track meets in elite athletes seeking a competitive advantage. 
 
Keywords 
Ischemia, reperfusion, anaerobic performance, oxygen uptake, accumulated oxygen 
deficit 
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Introduction 
 Ischemic preconditioning (IPC) was originally established as a protective 
mechanism in cardiac cells against a subsequent ischemic event. This process includes 
brief cycles of non-lethal reactive hyperemia, or periods of circulatory occlusion and 
reperfusion, causing a decreased formation of muscle damage [1]. The clinical 
applications protect the cardiac cells by triggering an up-regulation of energetics of the 
tissues to prevent cellular damage through a reduced formation of proinflammatory 
responses [2] and metabolic stress [3]. Some of these responses include an increase of 
blood flow [4,5] that initiates a release of vasoactive triggers [6]. As a result of the 
vascular responses caused by preconditioning, this method was applied to explore 
changes in exercise performance. The first study by de Groot et al. found that IPC 
improved exercise performance and maximal oxygen uptake in cyclists [7]. 
Additionally, other studies have shown that ischemic preconditioning elicits 
improvements in aerobic exercise in running [8], cycling [9], and swimming [10]. While 
research has shown an improved ability in aerobic exercise bouts, Jean-St-Michel et al. 
suggests that the aerobic energy transaction contributes to the anaerobic events, where 
the oxidative system is fully taxed [11]. Patterson et al. reported enhanced peak 
anaerobic power during twelve all-out 6 sec cycling sprints but no influence on fatigue 
or EMG activity of the vastus lateralis [12]. A recent study by Cruz and colleagues [13] 
showed that ischemic preconditioning resulted in greater oxygen consumption and 
quadriceps muscle activation during 45 min of active recovery following a 60 sec 
maximal cycling sprint, while showing improvements in performance by 2.1%. These 
findings imply that the rate of fatigue during subsequent short bouts of anaerobic cycling 
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could be reduced with preconditioning. Additionally, the aforementioned studies 
indicate potential improvement in anaerobic performance. One approach that has not 
been directly applied to determine the effects of preconditioning on anaerobic 
performance is the accumulated oxygen deficit (aO2D) method.  
 Accumulated oxygen deficit is a method to indirectly quantify anaerobic capacity 
of skeletal muscle during exercise [14].  It is a method based on the oxygen deficit 
concept, as the larger the oxygen deficit for a given bout of exercise, the greater must be 
the ATP contribution from non-mitochondrial sources (anaerobic).  If an exercise bout 
can be performed that maximally taxes the muscles’ abilities to regenerate ATP from 
non-mitochondrial sources, it would provide a means to determine the aO2D. The 
measurement of aO2D is done by calculating the difference between the estimated 
oxygen demand and the actual value that is obtained for oxygen uptake during an all-out 
supramaximal test. This is done by working out maximum oxygen consumption first, 
followed by a series of submaximal performance values for oxygen uptake. The 
submaximal performance values are used to draw a line of regression so that estimated 
oxygen uptake can be computed. Once this is done and the athlete performs an aO2D test 
at a supramaximal effort to exhaust the anaerobic system, the actual oxygen uptake is 
measured and taken away from the estimated value to get the oxygen deficit. 
 The direct investigation on the effects of preconditioning on maximal anaerobic 
performance determined by aO2D is very limited. Accumulated oxygen deficit data elicits 
the determination of the maximum oxidative response to measure maximum anaerobic 
capacity. The aim of this study is to determine the effect of remote ischemic 
preconditioning as it improves anaerobic capacity as assessed by the accumulated oxygen 
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deficit in NCAA Division I middle-distance track athletes. We hypothesize that the 
effects of preconditioning will improve the aO2D and performance in the runners.  
 
Methods 
Subjects 
Ten healthy, NCAA Division I Track middle-distance runners (age 21±1 yr) were 
studied: 6 men and 4 women. Track athlete event groups included those who competed in 
mid-distance events ranging from 800 meters to the mile (1609m). The subjects training 
distance was chosen due to the energy system in which they trained to grant accurate data 
collection for the type of supramaximal exercise induced by the aO2D tests. Subjects 
train all 12- months of the year and are in competition 9- months of the year. Subjects 
typically take one day off every 2-3 weeks. Each subject trained at a minimum of 30 
miles per week and as high as 90 miles per week. Male and female runners trained at an 
average speed of 14.8 km/hr and 13.4 km/hr, respectively. This study was conducted 
during the competition season, therefore, subjects continued training and competing 
throughout the study. The subjects completed the tests for this study on non-workout or 
high intensity days, i.e. rest days.  
 Upon enrollment, participants underwent a complete medical history and basic 
health assessment. Information concerning the use of medications, lifestyle and physical 
activity habits, and history of cardiovascular, pulmonary, or metabolic disease were 
documented. None of the subjects smoked, consumed tobacco-containing products, or 
were taking medications, including vitamins and performance-enhancing supplements. 
Participants were excluded from the study if they presented with a history of disease or 
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injury that precluded exercise participation. Before participation, informed consent was 
obtained from all individual participants included in the study. However, to lessen 
expectation bias, subjects were not informed of any potential exercise performance 
application of ischemic preconditioning. Subjects were instructed to continue normal 
training during the study. This study was conducted according to the Declaration of 
Helsinki and approved by the Institutional Review Board for the Protection of Human 
Subjects at South Dakota State University.  
 
Experimental design 
A simplified overview of the experimental protocol is shown in Figure 1. A randomized, 
double-blind, sham-controlled crossover design was used to investigate the influence of 
the acute remote ischemic preconditioning on the primary outcome in the difference of 
accumulated oxygen deficit (i.e., ischemic preconditioning or sham) separated by ~1 
week between trials. All subjects completed a series of pre-screening measurements 
including each subject’s VO2max for the first session. The following week the subject 
completed a 45-minute sub maximal treadmill running test. Following the submaximal 
test, subjects completed the first assessment of baseline aO2D test, followed by a 
randomized aO2D test with control or remote preconditioning for the proceeding week. 
Randomization was computer generated by a list and was kept blind to the primary 
researcher. After at least 7 days of washout, subjects crossed over to repeat the third 
aO2D test (remote preconditioning or control). 
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Figure 1. Experimental study design 
 
Hemodynamic measurements 
Non-dominant arm auscultatory resting systolic and diastolic blood pressure were 
measured using a stethoscope and sphygmomanometer (Diagnostic 700 Series; American 
Diagnostic Corporation, Hauppauge, NY, USA) following 5 min of seated quiet rest 
using standard procedures. Resting blood pressure measurements were performed twice 
separated by 3 min, and averaged. Resting heart rate was measured using a 60 sec radial 
pulse count. 
 
Anthropometric measurements 
Standing height was measured using a Detecto medical beam balance (Cardinal Scale 
Manufacturing Co, Webb City, MO, USA). Body mass was measured with a digital scale 
(Seca 876 digital scale, Seca Corporation, Hamburg, Germany). Body mass index was 
calculated as weight (kilograms) divided by height (meters) squared. Percent body fat 
was estimated by air displacement plethysmography (BODPOD, COSMED USA Inc., 
Illinois). 
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Maximal Oxygen Uptake 
Maximal oxygen uptake (VO2max) was determined using open-circuit spirometry 
combined with indirect calorimetry (Parvo Medics TrueOne® 2400, Salt Lake City, UT) 
in response to incremental treadmill running (Woodway Pro, Woodway USA, Waukesha, 
WI). Flow and gas calibration was performed prior to each test using standard operating 
procedures provide by the manufacturer. Subjects were equipped with a mouthpiece and 
nose clip, and a heart rate monitor affixed to the chest with receiver integrated with the 
metabolic cart (Polar Electro Inc., Lake Success, NY, USA). Resting expired gases were 
collected for 2 min. Thereafter, a 15 min warm-up was performed at 12.8 km/h and 13.7 
km/h for female and males, respectively. Velocity was increased or consistent (preferred 
pace) during the warm-up phase until a self-selected running pace was identified between 
12.8-14.3 km/h. The pace of the test was determined using each subject’s running tempo 
pace, based off of the individual’s 5k race pace. After a brief rest period, the first stage of 
the VO2max protocol was initiated and subjects ran at the predetermined velocity, based 
off of the subject’s race pace, at 0% incline for 2 min. Thereafter, the workload was 
increased by raising the velocity of the treadmill every 2 minutes until the third stage, or 
6 minutes. During the following stages, the incline of the treadmill increased by 2% as 
velocity increased every 2 min until volitional fatigue. The treadmill did not surpass a 
grade of 6% or below 4% at the subjects VO2max. Rating of perceived exertion was 
obtained at the end of each 2 min stage. Subjects were provided verbal encouragement 
throughout the test until exhaustion. Oxygen uptake (VO2), minute ventilation, heart rate, 
and kcals/min were recorded. VO2 data were smoothed with a 10-second moving average 
with VO2max denoted as the highest 10-second moving average obtained during the last 
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minute of exercise [15] with no further increase in VO2 (<150 mlO2/min) despite 
increased workload. All tests were terminated by volitional exhaustion. 
 
Submaximal Oxygen Uptake (45-minute running test) 
Submaximal oxygen uptake was determined using open-circuit spirometry combined 
with indirect calorimetry (Parvo Medics TrueOne® 2400, Salt Lake City, UT) in 
response to incremental treadmill running (Woodway Pro, Woodway USA, Waukesha, 
WI) at a 0% grade for 45 minutes. The protocol consisted of nine, 5-minute running 
stages of increasing intensity. The test initiated as ~50% of the VO2max of each subject 
and reached 80% but did not surpass. This test is designed for the subjects to reach 
steady-state exercise. Buck and McNaughton [16] studied the submaximal exercise bout 
which elicits a steady-state response to be achieved in running at 30-90% of the subjects 
VO2max. At fixed submaximal workloads below ventilatory threshold, steady-state 
conditions are usually reached within minutes after the onset of exercise. This protocol 
was used to determine the theoretical cost of oxygen at the intensity of the aO2D test, 
otherwise known as aO2D theoretical (see equations in aO2D section below). Subjects 
were equipped with a mouthpiece and nose clip, with a heart rate monitor affixed to the 
chest with the receiver integrated with the metabolic cart (Polar Electro Inc., Lake 
Success, NY, USA). Flow and gas calibration was performed prior to each test using 
standard operating procedures provided by the manufacturer. Resting expired gas was 
collected for 2 minutes prior to the test. Oxygen uptake, minute ventilation, and heart rate 
was recorded during the test. At the end of the 45 minute test, a 5 minute cool down was 
initiated immediately.  
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VO2 data was smoothed out with a 15 second moving average. The 15 second moving 
average was selected because it induces minimal data loss with little data and trend 
distortion as recommended by Robergs et al. [15]. Steady-state exercise data during the 
last two minutes of each 5-minute submaximal running stage was calculated from the 15 
second moving averages. This was obtained by averaging the final four data points for 
oxygen uptake, heart rate, minute ventilation, respiratory exchange ratio, and kcals/min. 
Due to the workload at a 0% grade, the work performed on the treadmill for the aO2D 
calculation was determined using the horizontal work (kg m/min), calculated by the 
speed (mph), multiplied by the subjects mass, adding that to the vertical work (kg m/s2) 
done by multiplying mass by gravity by subject’s height, as percent grade. The work 
performed on the treadmill during the submaximal test was used to calculate aO2D 
theoretical by plotting the steady-state oxygen uptake values against the workload 
performed. A linear relationship was determined for each subject by calculating the 
regression of the steady-state oxygen uptake on exercise intensity, or work, thus 
identifying the oxygen demand for all intensities. Table 3 shows the heart rate, oxygen 
uptake, and work performed at each stage. Heart rate, VO2, and RER were recorded to 
determine that each subject reached steady-state without exceeding for the purpose of 
keeping the test below maximum efforts, see Table 3 for values. This technique confirms 
the submaximal nature of the test, allowing accurate extrapolation of the linear data to 
represent the actual oxygen consumed.  
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Supramaximal (aO2D) Test 
 The Accumulated Oxygen Deficit (aO2D) test was used to determine the difference in 
oxygen demand and actual oxygen uptake. The test was designed as a supramaximal test 
at each of the subjects calculated 110% VO2max workload. The subjects performed the 
series of three aO2D tests separated each by one week; baseline, followed by either a state 
of remote preconditioning or sham, randomly. Prior to administering the aO2D trials, 
subjects were instructed to refrain from any exercise for 24 hours and to abstain from 
ingesting caffeine and any supplement or ergogenic aid that may enhance exercise 
performance. Subject began with a 15-minute warm-up at 12.8 km/h and 13.7 km/h for 
female and males, respectively. Subjects were allowed a 3-min break before an extended 
3-min warm-up performed at ~80% of their calculated treadmill running velocity of the 
test. This was followed by three-15 sec running sprints at their individual grade of 4%-
6% with up to 90% of the velocity of the respective test. The warm-up for each of the 
three tests was identical for each subject. Subjects were equipped with a mouthpiece and 
nose clip, with a heart rate monitor affixed to the chest with the receiver integrated with 
the metabolic cart (Polar Electro Inc., Lake Success, NY, USA). Flow and gas calibration 
was performed prior to each test using standard operating procedures provided by the 
manufacturer. Resting expired gas was collected for 2 minutes prior to the test. The 
subjects were instructed to run each test the same, by running until absolute volitional 
exhaustion. Subjects began the test at rest and advanced onto the moving belt at the 
selected speed and grade then exercised at the respective supramaximal intensity until 
exhaustion. Subjects were provided verbal encouragement throughout the test until 
exhaustion. The individual relationship between the time to exhaustion and oxygen 
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uptake (VO2) determined the corresponding oxygen demand in each test. The 
accumulated oxygen deficit was calculated as the difference between the accumulated 
oxygen demand and the actual accumulated oxygen uptake between tests:  
a. aO2D theoretical (ml/kg) = Oxygen demand theoretical (ml/kg/min) x duration (min) of 
aO2D test 
b. aO2D uptake actual (ml/kg) = Actual oxygen uptake (ml/kg/min) x duration (min) 
aO2D test 
 
VO2 data was smoothed out to breath-by-breath averaging using a 4-breath average to 
produce an accurate representation of the VO2 response for the short duration, high 
intensity test. Using the individual’s calculated 110% VO2max, the test was designed to 
cause volitional exhaustion within 3 minutes from initiation of the test. Due to the length 
of the test, the 4-breath averaging best suites the data for accurate interpretation of the 
VO2 data. VO2 data, heart rate, and respiratory exchange ratio was recorded for analysis 
and confirmation for true achievement of maximal oxygen uptake. Time to exhaustion for 
each test was collected and used to calculate aO2D for remote preconditioning and sham 
tests in comparison to baseline aO2D.  
 
Ischemic Preconditioning 
At least one week after completing the baseline aO2D measurement, subjects were 
randomized to complete either the ischemic preconditioning or the sham control trial 
first, each immediately followed by a aO2D test. All measurements were performed in a 
temperature-controlled room after a 4 hr fast. To induce ischemic preconditioning, 
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subjects rested in the supine position with high-pressure cuffs placed unilaterally on the 
upper right arm muscle and inflated to 220 mmHg (EC20 rapid cuff inflator, DE 
Hokanson, Inc., Bellevue, WA) for 5 min to occlude the brachial artery, followed by 5 
min of deflation (reperfusion). This procedure was repeated four additional times and was 
similar to the ischemic conditioning protocols employed by other exercise performance 
studies [7, 17]. Heart rate and blood pressure were monitored during the last 2 minutes of 
each 5 minute ischemic episode. The sham control trial consisted of the same procedure 
described above for the ischemic preconditioning trial except the pressure cuff were 
inflated to 20 mmHg to avoid ischemia and reperfusion. The total time to perform these 
trials was 40 min (i.e., 20 min of intermittent ischemia/sham and 20 min of intermittent 
reperfusion). Within 15 min following the ischemic preconditioning and sham trials, 
subjects were prepared to complete a supramaximal aO2D test. The rationale for electing 
to begin the aO2D trials within 15 minutes of preconditioning is based on the notion that 
the early window of cytoprotection is invoked within minutes after the preconditioning 
ischemia, disappearing 1-2 hours later [18]. However, it is important to note that the 
cytoprotective mechanisms have not been linked directly to improvements in exercise 
performance. To avoid experimenter bias, aO2D were completed by the same 
investigators blinded to the conditioning trial of each subject. All subjects wore the same 
athletic shoes for the three trials.  
 
Blood Lactate 
A small sample (0.7 µl) of capillary whole blood was obtained via finger prick from the 
index finger at the baseline and last two minutes of each 5-minute reperfusion stage 
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during preconditioning and sham control trials while lying in a supine position (Lactate 
Plus, Nova Biomedical, UK). A total of five samples were collected during each of the 
two trials. The Lactate Plus analyzer has been shown to provide valid and reliable 
(r=0.99) measurements of blood lactate concentration compared with bench top grade 
analyzers [19]. The analyzer was calibrated with low (1.0–1.6 mmol/l) and high (4.0–5.4 
mmol/l) quality control solutions prior to measurements. Lactate was obtained within one 
minute while the subject laid in a supine position during the trials. The same investigator 
measured blood lactate during each trial.  
 
Statistical Analysis 
Measures of central tendency were used to calculate baseline demographic data. 
Data were checked for normality and spread and were normally distributed with the 
exception of blood lactate concentrations. A three-way repeated-measures ANOVA with 
adjustment for multiple comparisons was used for within-group differences (i.e., baseline 
vs sham vs ischemic preconditioning) in aO2D. Linear regression was used to determine 
differences in the slope of the linear increase in oxygen uptake (mlO2/kg/min) relative to 
treadmill work (kgm) among aO2D trials. A 2×5 (trial × time) repeated measures 
ANOVA was used to determine differences in resting heart rate and blood pressure at the 
end of each 5 min ischemic/sham episode for the IPC and sham trials. Area under the 
lactate curve across IPC and sham trials was determined using a trapezoidal model. 
Differences in lactate between sham and IPC were determined using the non-parametric 
Wilcoxon sign rank test for within subjects’ designs. Statistical significance was set at 
P<0.05. Data are presented as means±SD and analyzed with SPSS version 20 (IBM, Inc., 
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Armonk, NY). 
Results 
 Subject characteristics are shown in Table 1. Subjects were considered normal 
weight based on BMI, normotensive, and presented with VO2max values at or above the 
90th percentile for age and sex [20]. Thirteen middle-distance athletes volunteered to 
participate in this study, three subjects dropped out each due to injury during training. 
Thereby, data was collected and analyzed for 10 subjects (6 men, 4 women). Each subject 
participated in five data collection sessions. On average, each session was at least one 
week apart. The maximum time between IPC and sham trials during the study was 2 
weeks; the average was 1 week apart for the subjects. Each subject continued normal 
track training during the study; the average weekly mileage was 50 miles per week in 
which the athlete trained. The subjects are all considered elite athletes in their field, 
where the mean VO2max was 65.0±7.3 ml/kg/min. Mean systolic blood pressure was 
128±13 mmHg and mean diastolic blood pressure was 72±7 mmHg.  
Table 1. Subject characteristics 
Variable Total Group (N=10) 
Sex, men/women 6 / 4 
Age, year         20 ± 1 
Body mass, kg         63.8 ± 8.4 
BMI, kg/m2         21.0 ± 1.4 
Percent Fat, % 10.1 ± 4.7 
Height, m 1.74 ± 0.1 
Systolic BP, mmHg      128 ± 13 
Diastolic BP, mmHg         72 ± 7 
RHR, bpm 52 ± 7 
VO2max, ml/kg/min 65.0 ± 7.3 
Values are mean ± SD. BMI: body mass index; BP: blood pressure; RHR, resting heart rate; VO2max, maximal 
oxygen consumption. 
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Table 2 shows the mean heart rate and blood pressure changes before and during the 5-
min bouts of sham and preconditioning.  
 
 
 
 
 
 
 
 
 
 
Table 2. Heart rate and blood pressure changes before and during four, 5 min bouts of unilateral sham and 
ischemic preconditioning of the arm.  
 Heart rate, bpm 
 Baseline 5 min 10 min 15 min 20 min 
Sham 55±9 56±10 55±8 55±8 56±8 
Ischemic preconditioning 53±12 53±15 52±7 51±8 52±6 
 Systolic/Diastolic Blood pressure, mmHg 
 Baseline 5 min 10 min 15 min 20 min 
Sham 118/62±10/5 118/60±9/5 115/60±11/5 116/61±12/6 116/61±12/6 
Ischemic preconditioning 120/64±8/6 118/65±9/6 117/63±9/5 116/63±8/7 118/61±9/7 
Values are means±SD.  
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Table 3 shows steady-state heart rate, oxygen uptake and RER during the 9 stage 
submaximal running trial. There were progressive increases (all P<0.01) in heart rate, 
oxygen uptake and RER, as expected across stages. 
Table 3. Steady-state heart rate, oxygen uptake, and RER during 45-minute submaximal test 
to determine oxygen demand.  
Stage 1 
Heart rate 
(bpm) 135±12 
VO2 37±5 
RER 0.825±0.045 
Stage 2  
Heart rate 
(bpm) 142±9 
VO2 39±4 
RER 0.863±0.052 
Stage 3  
Heart rate 
(bpm) 150±10 
VO2 41±4 
RER 0.859±0.052 
Stage 4  
Heart rate 
(bpm) 155±12 
VO2 43±4 
RER 0.865±0.054 
Stage 5  
Heart rate 
(bpm) 159±11 
VO2 45±5 
RER 0.860±0.057 
Stage 6  
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Heart rate 
(bpm) 162±11 
VO2 47±8 
RER 0.862±0.048 
Stage 7  
Heart rate 
(bpm) 167±11 
VO2 48±6 
RER 0.879±0.048 
Stage 8  
Heart rate 
(bpm) 172±11 
VO2 50±16 
RER 0.885±0.057 
Stage 9  
Heart rate 
(bpm) 176±12 
VO2 51±8 
RER 0.898±0.060 
Data represent mean±SD. IPC, ischemic preconditioning; VO2, oxygen uptake; RER, 
respiratory exchange ratio.   
 
Effects of Ischemic Preconditioning on Supramaximal Time to Exhaustion  
Figure 2(a) below, illustrates the time to exhaustion during the supramaximal exercise 
tests between groups (A) baseline, (B) sham, (C) IPC, reporting time and standard 
deviation. Ischemic preconditioning (122±38 sec) significantly increased (P=0.0001) time 
to exhaustion compared to baseline (99±23 sec, 95% CI: 4.8-40.6, P=0.014) and sham 
(101±30 sec, 95% CI: 6.7-34.2, P=0.001). Time to exhaustion increased by 22% in the 
ischemic preconditioning trial compared to baseline and sham trials. Effect size for the 
differences in trial as estimated by the Partial Eta2 (0.58) were large. There were no 
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statistical differences in time to exhaustion between baseline and sham (P=1.0). There 
were also no significant differences in maximum heart rate between trials. 
 
Effects of Ischemic Preconditioning on Accumulated Oxygen Deficit 
The values reported in Table 3 were used to calculate the linear regression of work and 
oxygen demand to determine the oxygen uptake. Figure 2(b) below, illustrates the results 
showing that aO2D increased significantly with ischemic preconditioning (P=0.009) 
compared to baseline and SHAM trials in the supramaximal exercise tests. The ischemic 
preconditioning aO2D measured 46±35 mlO2·kg-1 (Partial Eta2 = 0.43), significantly 
increased from baseline (35±27 mlO2·kg-1, P=0.025, 95% CI:1.3-19.2) and sham (38±32 
mlO2·kg-1, P=0.046, 95% CI: 0.13-14.0). There were no statistical differences in aO2D 
between baseline and SHAM trials. 
  
Figure 2. (a) Time to Exhaustion (sec) (b) aO2D between baseline, sham, and 
preconditioning (ml/kg) 
 
* denotes significance 
a.    b.  
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Lactate  
Figure 3 below, shows box and whisker plots of resting blood lactates for the sham and 
ischemic preconditioning trials. The data was analyzed using a Wilcoxon Signed Rank 
Test. There was a significant decrease in resting blood lactate during the ischemic 
preconditioning trial (median=3.5 mmol/l, Z=2.0, P=0.047) compared to sham trial. For 
example, median lactate decreased from 4.6 and with an IQR of 3.7 mmol/l to 5.5 mmol/l 
in the sham trial to 3.5 mmol/l, with the IQR of 2.8 mmol/l to 4.5 mmol/l with ischemic 
preconditioning. 
 
Figure 3. Total lactate area under the curve showing the significant decrease in resting 
lactate (mmol/L) taken during the sham and IPC trials. There is a significant decrease 
(p=0.047) in resting blood lactate from sham to preconditioning trials. 
 
* denotes significance 
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Discussion 
 In the present study, remote preconditioning in the upper arm did significantly 
affect maximal accumulated oxygen deficit and anaerobic performance in elite, middle-
distance runners. Relative to the baseline control, preconditioning improved time to 
exhaustion by 22%. This result is in agreement with previous studies of Jean-St-Michel et 
al. [11] and Cruz et al. [13], where they observed similar benefits of preconditioning on 
anaerobic performance in swimmers and cyclists, respectively. In the latter study, by 
Cruz et al., performance differences were identified by a greater anaerobic contribution, 
rather than aerobic sources. These findings are consistent with the present study, 
determining the improvement upon the anaerobic energy system, causing a greater 
capacity for anaerobic exercise and maximal intensities.  
 The studies investigating the effect of preconditioning on anaerobic performance 
have been inconsistent. Gibson et al. [21] and Clevidence et al. [17] reported inconclusive 
findings for anaerobic performance in a 5 by 6-sec sprint on a cycle ergometer and time 
to exhaustion in amateur cyclists. Additionally, Akgul et al. [22] and Lalonde et al. [23] 
both recently studied anaerobic power using a 30-sec Wingate Test on trained athletes, 
but did not find significance in mean power or power output after preconditioning. These 
findings suggest that preconditioning does not have an effect on peak power or maximal 
power output, where ATP is being recruited by the ATP-PC system and therefore, we can 
expect to see no significant improvements on bouts of intense, short exercise (< 30-sec). 
Alternatively, research by Jean-St-Michel et al. [11] suggests that energy recruited from 
additional pathways such as the anaerobic glycolytic as well as the aerobic oxidative 
system, may have more of an effect on performance in athletes. While the study shows 
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complementary findings to our previous analysis showing no effect on submaximal 
exercise, Jean-St-Michel et al. found a significant association between maximal 
performance following preconditioning. The methods analyzed swim-time performance 
in 100-m and 200-m swimming test in a competitive setting suggesting additional energy 
recruitment. These findings may be interpreted by in vivo studies performed by Fryer et 
al. [24], showing that IPC causes mitochondrial ATP-sensitive K channels to open and 
the uncoupling of oxidative phosphorylation. As a result, it is hypothesized that this 
allows the mitochondria uptake acetyl-CoA as a by-product of glycolysis more quickly. 
This allows for the maintenance of lactic acid accumulation and use during exercise. 
Bailey et al. [8] suggests that IPC can elicit a greater contribution from aerobic pathways 
allowing for the sparing of ATP generated by glycolysis via the ability to produce and 
efficiently use lactate. Our study is consistent with this concept, as resting blood lactate 
significantly decreased with preconditioning, compared to sham (p= 0.047). We speculate 
that the decrease in resting lactate during preconditioning caused an up-regulation of 
lactic acid as an energy source pre-exercise causing a potential augmentation of blood 
lactate clearance and enhanced oxidation rates. Along with lactate, other improvements 
caused by IPC include vasodilation inducing increased blood flow and ATP sparing 
derived from anaerobic pathways [25]. Additionally, we speculate that more muscle 
fibers are recruited following IPC, which allow for higher muscle activation potentials 
[13] and the possibility of the subject to exercise beyond the threshold of fatigue. One 
explanation of this phenomenon is explained by Barbosa et al. [26], that suggests 
preconditioning delays the development of fatigue possibly due to the blocking of fatigue 
receptors within the central nervous system. This may allow athletes to perform at 
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supramaximal workloads with the delay in development of fatigue with the greater 
increase of sympathetic activity. As a result in our present study, this mechanism needs 
further investigation to determine the cellular activity after preconditioning. 
 Unique in this study is the method of using accumulated oxygen deficit as a 
measure of anaerobic capacity and performance. To date, this is the first study that uses 
this method as a measurement for performance in this setting.  Additionally, we are the 
first study to use a baseline bout of exercise to determine the changes from baseline and 
sham trials. This strengthens the results of our study as the improvements from IPC were 
significant from baseline (p=0.0001) and sham (p=0.001) trials. Accumulated oxygen 
deficit is an accurate method of determining ATP production from anaerobic metabolism. 
As this method determines the anaerobic capacity by determining the energy source 
through oxygen demand during a supramaximal effort; it is potentially the most precise 
method for our population. As the running intensity of the 800m and mile run both 
exceed 100% VO2max, the aerobic and anaerobic energy metabolisms contribute to these 
races; theoretically 60% aerobic and 40% anaerobic reported by di Prampero et al. [27]. 
The anaerobic energy system increases oxygen uptake before and after an 800m run, 
which is significant for the requirement to resynthesize lactic acid during the run [28]. 
Therefore, it is necessary for these athletes to have a high anaerobic capacity. By using 
the aO2D method, we could measure the effect of preconditioning on anaerobic capacity 
and potentially further warrant an increase in performance in middle-distance runners.  
 Another distinguishing element of this study is the elite population researched. 
This population of elite athletes is exclusive, as other studies have only included at 
recreational, amateur, and sedentary individuals. Additionally, there is limited research 
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assessing the effects of preconditioning on anaerobic capacity in runners using land-
based sprinting methods. The significance in the results can be verified due to the 
runner’s ability to perceive true physical exhaustion, while other indicators confirmed 
fatigue such as an RER > 1.10 and a VO2 exceeding the subject’s maximum, indicating 
supramaximal efforts. The significance of this study potentially gives middle-distance 
runners a competitive edge. Within this group of athletes, milliseconds might separate 
competitors in the respective events. This study may contribute to the development of a 
natural aid for this population, as we concluded this study with a 22% improvement in 
time to exhaustion from baseline at a workload similar to a racing performance. The 23-
sec average increase in time was not only significant but also potentially competitively 
significant for runners, where a 0.4% improvement in competition performance is 
reported as significant [29]. With the observed improvements of our study, more research 
should be done to support preconditioning as a natural performance enhancer in 
competitive runners.  
 
Conclusions 
 The results of the study suggest that upper arm ischemic preconditioning 
improves accumulated oxygen deficit and time to exhaustion in elite, middle-distance 
track athletes.  Further studies should be conducted to determine the effects on 
performance to the track and field setting to evoke possible improvements in competition 
for elite athletes seeking a competitive advantage.  
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Figure Captions 
 
Fig 1. Simplified overview of the main experimental protocol. Subjects will first undergo 
an assessment of maximal cardiorespiratory fitness (Day 1). At a maximum of 1 week 
later (Day 7), subjects will complete the first assessment of accumulated oxygen deficit. 
At approximately Day 14, subjects will complete a 45 min running test. Subjects will be 
randomized to undergo a second accumulated oxygen deficit test with control or with 
remote preconditioning. After about 7 days of washout, subjects will crossover to repeat a 
third accumulated oxygen deficit test (i.e., with remote preconditioning or control). 
 
Fig 2. (a) This figure illustrates a significant increase in time to exhaustion (sec) in the 
aO2D test following preconditioning compared to baseline (p=0.0001) and sham 
(p=0.001) trials. (b) This figure illustrates a significant increase in accumulated oxygen 
deficit (ml/kg) in the preconditioning trial (0.009) compared to baseline and sham. 
 
Fig 3. Total lactate area under the curve illustrates the significant decrease in resting 
lactate (mmol/L) measurements taken during the sham and preconditioning trials. There 
is a significant decrease (p=0.047) in resting blood lactate from sham to preconditioning 
trials.  
